|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2000-9-7
|
|
pubmed:abstractText |
Tamoxifen-treated breast carcinoma survivors are at elevated risk of endometrial carcinoma. Whether to recommend annual surveillance for uterine abnormalities in this population is currently under debate.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2000 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
800-10
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10951343-Adult,
pubmed-meshheading:10951343-Aged,
pubmed-meshheading:10951343-Antineoplastic Agents, Hormonal,
pubmed-meshheading:10951343-Breast Neoplasms,
pubmed-meshheading:10951343-Community Health Services,
pubmed-meshheading:10951343-Cross-Sectional Studies,
pubmed-meshheading:10951343-Endometrial Neoplasms,
pubmed-meshheading:10951343-Female,
pubmed-meshheading:10951343-Humans,
pubmed-meshheading:10951343-Maryland,
pubmed-meshheading:10951343-Middle Aged,
pubmed-meshheading:10951343-Population Surveillance,
pubmed-meshheading:10951343-Tamoxifen,
pubmed-meshheading:10951343-Uterine Diseases
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Surveillance for uterine abnormalities in tamoxifen-treated breast carcinoma survivors: a community based study.
|
|
pubmed:affiliation |
Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
